Skip to product information

DYRONIB 70MG TAB

Vendor: DYRONIB
Availability: In stock
Product type: Oncology
Composition: DASATINIB
Strength: 70MG
Dosage Form: Tablet

Prescription Required

Sale price  ₹ 1,900.00 Regular price  MRP: ₹ 17,811.56 89% OFF
Inclusive of all taxes.
DYRONIB 70MG TAB
Regular price ₹ 1,900.00
Regular price ₹ 17,811.56 Sale price ₹ 1,900.00 (-89%)
Strength: 70MG
Dosage Form: Tablet
DYRONIB 70MG TAB
DYRONIB 70MG TAB
Sale price  ₹ 1,900.00 Regular price  MRP: ₹ 17,811.56 89% OFF

Introduction

Dyronib 70mg Tablet contains dasatinib, a targeted tyrosine kinase inhibitor that suppresses the growth of abnormal blood cancer cells.

Uses

Dyronib 70mg Tablet is used for the treatment of Philadelphia chromosome-positive blood cancers.

  • Chronic myeloid leukaemia (CML).
  • Acute lymphoblastic leukaemia (ALL).

Storage

  • Store below 30°C in a dry place.
  • Keep away from heat, moisture and direct sunlight.

Safety Information

  • Monitor blood counts, liver function and cardiac status regularly.
  • Inform your doctor about bleeding disorders or infections before use.

Possible Side Effects

Possible side effects may include:

  • Low blood cell counts
  • Fatigue
  • Nausea
  • Diarrhoea
  • Pleural effusion
  • Bleeding
  • Infections

About RareMeds

We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.

The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.

No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.

Disclaimer

Dyronib is a prescription anticancer medicine.

It is intended for use only under specialist medical supervision.

Related Products